DAWN - Day One Biopharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$21.50
DETAILS
HIGH:
$21.50
LOW:
$21.50
MEDIAN:
$21.50
CONSENSUS:
$21.50
DOWNSIDE:
0.14%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 158.2 | 131.2 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 17.2 | 5.3 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 141.0 | 125.9 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | |||||||
| R&D Expenses | 148.1 | 227.7 | 130.5 | 85.6 | 43.6 | 9.1 | 13.9 |
| SG&A Expenses | 120.6 | 115.5 | 75.5 | 61.3 | 29.2 | 4.7 | 1.0 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | (0.0) | 0 |
| Operating Expenses | 268.7 | 343.2 | 206.1 | 146.9 | 72.7 | 13.8 | 14.9 |
| Operating Income | |||||||
| Operating Income | (127.8) | (217.3) | (206.1) | (146.9) | (72.7) | (13.8) | (14.9) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0.0 | 2.1 |
| Interest Income | 18.5 | 19.7 | 17.2 | 4.7 | 0.0 | 0 | 0 |
| Profitability | |||||||
| EBITDA | (124.0) | (215.2) | (205.7) | (146.4) | (72.5) | 16.4 | (0.0) |
| EBIT | (127.8) | (217.3) | (206.1) | (146.9) | (72.7) | 0 | (14.9) |
| Income Before Tax | (109.3) | (88.4) | (188.9) | (142.2) | (72.8) | (43.8) | (17.0) |
| Income Tax Expense | (2.0) | 7.1 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (107.3) | (95.5) | (188.9) | (142.2) | (70.6) | (40.5) | (12.6) |
| Per Share Data | |||||||
| EPS (Basic) | -1.04 | -1.02 | -2.37 | -2.02 | -1.14 | -0.65 | -0.24 |
| EPS (Diluted) | -1.04 | -1.02 | -2.37 | -2.02 | -1.14 | -0.65 | -0.24 |
| Shares Outstanding | 103.4 | 93.6 | 79.8 | 65.5 | 62.0 | 61.9 | 61.9 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 197.1 | 125.0 | 230.8 | 85.3 | 284.3 | 43.7 | 27.3 |
| Short-Term Investments | 244.0 | 406.8 | 135.6 | 257.0 | 0 | 0 | 0 |
| Net Receivables | 26.7 | 13.9 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 6.3 | 3.3 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 10.9 | 4.4 | 2.4 | 1.0 | 1.0 | 1.3 | 0 |
| Total Current Assets | 485.1 | 562.3 | 375.3 | 347.9 | 289.4 | 45.1 | 27.3 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 4.5 | 4.7 | 0.6 | 0.7 | 0.3 | 0.5 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 18.0 | 15.6 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0.2 | 0.1 | 0.2 | 0.5 | 0.2 | 0.1 | 0 |
| Total Non-Current Assets | 22.7 | 20.5 | 0.8 | 1.2 | 0.5 | 0.6 | 0 |
| Total Assets | 507.8 | 582.8 | 376.0 | 349.1 | 289.8 | 45.7 | 27.3 |
| Current Liabilities | |||||||
| Account Payables | 3.7 | 3.3 | 2.6 | 0.3 | 1.7 | 0.2 | 0.1 |
| Short-Term Debt | 0.2 | 0.0 | 0.4 | 0.4 | 0.2 | 0 | 0 |
| Deferred Revenue | 2 | 1.6 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 54.6 | 54.7 | 17.4 | 9.8 | 0.1 | 0.0 | 1.5 |
| Total Current Liabilities | 60.5 | 73.5 | 29.5 | 16.6 | 8.7 | 2.0 | 2.0 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 2.6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 3.5 | 0.8 | 0 | 0 | 0 | 0 | 30.5 |
| Total Non-Current Liabilities | 6.1 | 6.6 | 0 | 0.4 | 0.0 | 0.2 | 30.5 |
| Total Liabilities | 66.7 | 80.0 | 29.5 | 17.0 | 8.7 | 2.2 | 32.5 |
| Stockholders' Equity | |||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.6 | 2 |
| Retained Earnings | (661.4) | (554.1) | (458.6) | (269.7) | (127.5) | (56.8) | (12.8) |
| Accumulated Other Comprehensive Income | 0.1 | 0.1 | 0.0 | (0.1) | 0 | 0 | 0.0 |
| Total Stockholders' Equity | 441.2 | 502.8 | 346.5 | 332.0 | 281.1 | 37.8 | (10.7) |
| Total Liabilities & Equity | 507.8 | 582.8 | 376.0 | 349.1 | 289.8 | 45.7 | 27.3 |
| Debt Metrics | |||||||
| Total Debt | 2.8 | 2.6 | 0.4 | 0.8 | 0.2 | 0.4 | 0 |
| Net Debt | (194.3) | (122.4) | (230.4) | (84.4) | (284.1) | (43.3) | (27.3) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (107.3) | (95.5) | (188.9) | (142.2) | (72.8) | (43.8) | (17.0) |
| Depreciation & Amortization | 3.5 | 2.0 | 0.4 | 0.5 | 0.2 | 0.2 | 0 |
| Stock-Based Compensation | 44.4 | 48.3 | 39.3 | 27.2 | 13.3 | 0.5 | 0.1 |
| Change in Working Capital | (28.9) | 26.5 | 9.4 | 6.6 | 2.7 | (0.4) | 0.4 |
| Other Non-Cash Items | (15.4) | (59.4) | (7.1) | (2.0) | 8 | 30.0 | 11.9 |
| Operating Cash Flow | (103.8) | (78.1) | (146.9) | (109.9) | (48.5) | (13.5) | (4.5) |
| Investing Activities | |||||||
| Capital Expenditure | (0.3) | (2.2) | (3.2) | (0.0) | (8) | (0.1) | 0 |
| Acquisitions | 0 | 0 | 0 | 0.3 | 0 | 0 | 0 |
| Purchases of Investments | (695.8) | (658.6) | (443.8) | (394.2) | 0 | 0 | 0 |
| Sales/Maturities of Investments | 874.2 | 393.9 | 575.4 | 139.2 | 0 | 0 | 0 |
| Other Investing Activities | (3.5) | 35.9 | (3) | (0.3) | 0 | 0 | 0 |
| Investing Cash Flow | 174.6 | (231.0) | 128.4 | (255.1) | (8) | (0.1) | 0 |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 25.1 | 0 | 4.3 | 0.3 | 0 | 0 |
| Financing Cash Flow | 1.2 | 203.3 | 164.0 | 165.9 | 297.1 | 30.0 | 30.9 |
| Cash Position | |||||||
| Net Change in Cash | 72.1 | (105.8) | 145.5 | (199.0) | 240.6 | 16.4 | 26.4 |
| Cash at Beginning | 125.0 | 230.8 | 85.3 | 284.3 | 43.7 | 27.3 | 0.9 |
| Cash at End | 197.1 | 125.0 | 230.8 | 85.3 | 284.3 | 43.7 | 27.3 |
| Free Cash Flow | (104.1) | (80.3) | (150.1) | (109.9) | (56.5) | (13.6) | (4.5) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 158.2 | 131.2 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 141.0 | 125.9 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | (127.8) | (217.3) | (206.1) | (146.9) | (72.7) | (13.8) | (14.9) |
| Net Income | (107.3) | (95.5) | (188.9) | (142.2) | (70.6) | (40.5) | (12.6) |
| EPS (Diluted) | -1.04 | -1.02 | -2.37 | -2.02 | -1.14 | -0.65 | -0.24 |
| Balance Sheet | |||||||
| Cash & Equivalents | 197.1 | 125.0 | 230.8 | 85.3 | 284.3 | 43.7 | 27.3 |
| Total Assets | 507.8 | 582.8 | 376.0 | 349.1 | 289.8 | 45.7 | 27.3 |
| Total Debt | 2.8 | 2.6 | 0.4 | 0.8 | 0.2 | 0.4 | 0 |
| Stockholders' Equity | 441.2 | 502.8 | 346.5 | 332.0 | 281.1 | 37.8 | (10.7) |
| Cash Flow | |||||||
| Operating Cash Flow | (103.8) | (78.1) | (146.9) | (109.9) | (48.5) | (13.5) | (4.5) |
| Capital Expenditure | (0.3) | (2.2) | (3.2) | (0.0) | (8) | (0.1) | 0 |
| Free Cash Flow | (104.1) | (80.3) | (150.1) | (109.9) | (56.5) | (13.6) | (4.5) |